HBV integrants of hepatocellular carcinoma cell lines contain an active enhancer

M. Shamay, R. Agami, Y. Shaul

Research output: Contribution to journalArticle

Abstract

Hepatitis B virus (HBV) infection is a major risk factor worldwide for the development of hepatocellular carcinoma (HCC). Integrated HBV DNA fragments, often highly rearranged, are frequently detected in HCC. In woodchuck, the viral enhancer plays a central role in hepatocarcinogenesis, but in humans the mechanism of HBV oncogenesis has not been established. In this study we investigated the status of the viral enhancer in two human HCC cell lines, Hep3B and PLC/PRF/5 each containing one or more integrated HBV DNA fragments. Active enhancer was defined by virtue of its protein occupancy as determined by genomic in vivo DMS footprinting. In PLC/PRF/5 cells, the HBV DNA was integrated in a cellular gene at chromosome 11q13, at a locus reported to be amplified in many tumors. We show here that in both cell lines, the integrated HBV DNA fragments contain an active enhancer-I. In particular, the occupation of the two previously defined basic enhancer elements, E and EP, was prominent. While in both cell lines the same protein binds to the EP elements, the E element, however, is occupied in a cell-line specific manner. In PLC/PRF/5 but not Hep3B, the prominent binding of an undefined protein was detected. Our data suggest that this protein is likely to be the fetoprotein transcription factor (FTF). The finding that enhancer sequences are conserved and functional in different cell lines suggests a selection pressure for their long-term maintenance. We therefore propose that the HBV enhancer-I might play a role in hepatocellular carcinogenesis. Oncogene (2001) 20, 6811-6819.

Original languageEnglish (US)
Pages (from-to)6811-6819
Number of pages9
JournalOncogene
Volume20
Issue number47
DOIs
StatePublished - Oct 18 2001
Externally publishedYes

Fingerprint

Hepatitis B virus
Hepatocellular Carcinoma
Cell Line
DNA
Carcinogenesis
Marmota
Proteins
Virus Diseases
Oncogenes
Occupations
Carrier Proteins
Chromosomes
Pressure
Genes
Neoplasms

Keywords

  • Fetoprotein transcription factor (FTF)
  • HBV enhancer
  • In vivo footprinting
  • Onco-DNA

ASJC Scopus subject areas

  • Molecular Biology
  • Cancer Research
  • Genetics

Cite this

HBV integrants of hepatocellular carcinoma cell lines contain an active enhancer. / Shamay, M.; Agami, R.; Shaul, Y.

In: Oncogene, Vol. 20, No. 47, 18.10.2001, p. 6811-6819.

Research output: Contribution to journalArticle

Shamay, M. ; Agami, R. ; Shaul, Y. / HBV integrants of hepatocellular carcinoma cell lines contain an active enhancer. In: Oncogene. 2001 ; Vol. 20, No. 47. pp. 6811-6819.
@article{10191f6f490a46aebc0c5c919b545bb5,
title = "HBV integrants of hepatocellular carcinoma cell lines contain an active enhancer",
abstract = "Hepatitis B virus (HBV) infection is a major risk factor worldwide for the development of hepatocellular carcinoma (HCC). Integrated HBV DNA fragments, often highly rearranged, are frequently detected in HCC. In woodchuck, the viral enhancer plays a central role in hepatocarcinogenesis, but in humans the mechanism of HBV oncogenesis has not been established. In this study we investigated the status of the viral enhancer in two human HCC cell lines, Hep3B and PLC/PRF/5 each containing one or more integrated HBV DNA fragments. Active enhancer was defined by virtue of its protein occupancy as determined by genomic in vivo DMS footprinting. In PLC/PRF/5 cells, the HBV DNA was integrated in a cellular gene at chromosome 11q13, at a locus reported to be amplified in many tumors. We show here that in both cell lines, the integrated HBV DNA fragments contain an active enhancer-I. In particular, the occupation of the two previously defined basic enhancer elements, E and EP, was prominent. While in both cell lines the same protein binds to the EP elements, the E element, however, is occupied in a cell-line specific manner. In PLC/PRF/5 but not Hep3B, the prominent binding of an undefined protein was detected. Our data suggest that this protein is likely to be the fetoprotein transcription factor (FTF). The finding that enhancer sequences are conserved and functional in different cell lines suggests a selection pressure for their long-term maintenance. We therefore propose that the HBV enhancer-I might play a role in hepatocellular carcinogenesis. Oncogene (2001) 20, 6811-6819.",
keywords = "Fetoprotein transcription factor (FTF), HBV enhancer, In vivo footprinting, Onco-DNA",
author = "M. Shamay and R. Agami and Y. Shaul",
year = "2001",
month = "10",
day = "18",
doi = "10.1038/sj.onc.1204879",
language = "English (US)",
volume = "20",
pages = "6811--6819",
journal = "Oncogene",
issn = "0950-9232",
publisher = "Nature Publishing Group",
number = "47",

}

TY - JOUR

T1 - HBV integrants of hepatocellular carcinoma cell lines contain an active enhancer

AU - Shamay, M.

AU - Agami, R.

AU - Shaul, Y.

PY - 2001/10/18

Y1 - 2001/10/18

N2 - Hepatitis B virus (HBV) infection is a major risk factor worldwide for the development of hepatocellular carcinoma (HCC). Integrated HBV DNA fragments, often highly rearranged, are frequently detected in HCC. In woodchuck, the viral enhancer plays a central role in hepatocarcinogenesis, but in humans the mechanism of HBV oncogenesis has not been established. In this study we investigated the status of the viral enhancer in two human HCC cell lines, Hep3B and PLC/PRF/5 each containing one or more integrated HBV DNA fragments. Active enhancer was defined by virtue of its protein occupancy as determined by genomic in vivo DMS footprinting. In PLC/PRF/5 cells, the HBV DNA was integrated in a cellular gene at chromosome 11q13, at a locus reported to be amplified in many tumors. We show here that in both cell lines, the integrated HBV DNA fragments contain an active enhancer-I. In particular, the occupation of the two previously defined basic enhancer elements, E and EP, was prominent. While in both cell lines the same protein binds to the EP elements, the E element, however, is occupied in a cell-line specific manner. In PLC/PRF/5 but not Hep3B, the prominent binding of an undefined protein was detected. Our data suggest that this protein is likely to be the fetoprotein transcription factor (FTF). The finding that enhancer sequences are conserved and functional in different cell lines suggests a selection pressure for their long-term maintenance. We therefore propose that the HBV enhancer-I might play a role in hepatocellular carcinogenesis. Oncogene (2001) 20, 6811-6819.

AB - Hepatitis B virus (HBV) infection is a major risk factor worldwide for the development of hepatocellular carcinoma (HCC). Integrated HBV DNA fragments, often highly rearranged, are frequently detected in HCC. In woodchuck, the viral enhancer plays a central role in hepatocarcinogenesis, but in humans the mechanism of HBV oncogenesis has not been established. In this study we investigated the status of the viral enhancer in two human HCC cell lines, Hep3B and PLC/PRF/5 each containing one or more integrated HBV DNA fragments. Active enhancer was defined by virtue of its protein occupancy as determined by genomic in vivo DMS footprinting. In PLC/PRF/5 cells, the HBV DNA was integrated in a cellular gene at chromosome 11q13, at a locus reported to be amplified in many tumors. We show here that in both cell lines, the integrated HBV DNA fragments contain an active enhancer-I. In particular, the occupation of the two previously defined basic enhancer elements, E and EP, was prominent. While in both cell lines the same protein binds to the EP elements, the E element, however, is occupied in a cell-line specific manner. In PLC/PRF/5 but not Hep3B, the prominent binding of an undefined protein was detected. Our data suggest that this protein is likely to be the fetoprotein transcription factor (FTF). The finding that enhancer sequences are conserved and functional in different cell lines suggests a selection pressure for their long-term maintenance. We therefore propose that the HBV enhancer-I might play a role in hepatocellular carcinogenesis. Oncogene (2001) 20, 6811-6819.

KW - Fetoprotein transcription factor (FTF)

KW - HBV enhancer

KW - In vivo footprinting

KW - Onco-DNA

UR - http://www.scopus.com/inward/record.url?scp=0035909521&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035909521&partnerID=8YFLogxK

U2 - 10.1038/sj.onc.1204879

DO - 10.1038/sj.onc.1204879

M3 - Article

VL - 20

SP - 6811

EP - 6819

JO - Oncogene

JF - Oncogene

SN - 0950-9232

IS - 47

ER -